Get started Log in

MAB — Mabion SA Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapMomentum Trap

Market Cap
PLN124.93m
Enterprise Value
PLN143.63m
Revenue
PLN15.76m

Brief: Mabion Signs Expansion Of Production Deal With Novavax
02/08/2022 17:24
Brief: Mabion Expands Cooperation With Novavax
06/07/2022 09:10
Brief: Mabion Signs Statement Of Work With Novavax
08/06/2022 13:12
Brief: Mabion Signs Extension To The Scope Of Services Under Deal With Novavax
30/05/2022 06:37
Brief: Mabion Q1 Net Result Turns To Profit Of 7.4 Mln Zlotys
27/05/2022 07:04
Brief: Mabion AGM To Vote on Retaining 2021 Net Profit To Cover Previous Losses
26/05/2022 07:30
Brief: Mabion 2021 Net Result Turns To Profit Of 1.9 Mln Zlotys
22/04/2022 07:12
Brief: Mabion Signs Annex To Financing Deal With MFiPR
19/04/2022 13:21
Brief: Mabion Resigns From Further Implementation Of MabionEGFR Research Project
24/02/2022 07:38
Brief: Mabion Signs Statement Of Work With Novavax
18/01/2022 16:24
Brief: Mabion Gets Additional Order For Production Of Cell Banks Under Deal With Novavax
14/01/2022 07:28
Brief: Mabion Gets Permission For Carrying Out Clinical Research In Ukraine
20/12/2021 17:10
Brief: Mabion Signs Deal With Swiss-Based Adolf Kühner
30/11/2021 14:40
Brief: Mabion Q3 Net Loss Widens To 15.6 Mln Zlotys
29/11/2021 17:23
Brief: Mabion Signs Quality Agreement With Novavax
19/11/2021 16:53
Brief: Mabion Says Mylan Ireland Terminates Cooperation Deal
18/11/2021 07:51
Brief: Mabion Gets Permission To Carry Out Bridge Clinical Trial Of MabionCD20 In Patients With Rheumatoid Arthritis In Belgium
22/10/2021 14:27
Brief: Mabion Gets Permission To Run Bridging Clinical Trial Of MabionCD20 Drug in Georgia
14/10/2021 11:22
Brief: Mabion Gets Permission For Briding Clinical Trial Of MabionCD20 Drug For Rheumatoid Arthritis Patients
11/10/2021 17:31
Brief: Poland's Mabion CEO Says Term For Finding Strategic Investor May Extend Beyond 2021
08/10/2021 10:23